カテゴリ： MarketLine, 中国, 企業調査

Sinopharm Group Co Limited：企業の戦略・SWOT・財務分析

◆英語タイトル：Sinopharm Group Co Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4711
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：44
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：中国
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Sinopharm Group Co Limited – Strategy, SWOT and Corporate Finance Report
Summary

Sinopharm Group Co Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sinopharm Group Co. Limited (Sinopharm or ‘the group’) is a distributor of healthcare products in China. It provides products such as pharmaceutical products, medical equipments, chemical reagents and laboratory supplies. Sinopharm provides supply chain solutions, logistics and distribution and other value-added services to domesticandforeignmanufacturer and suppliers of pharmaceutical products, medical equipment and supplies and other healthcare products. The group also offers health consultation, medical consulting, market information consulting and investigation, convention and exhibition services. It caters hospitals, other distributors, retail drug stores and primary health services institutions. The company is headquartered in Changning District, Shanghai, China.

Scope

- Detailed information on Sinopharm Group Co Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sinopharm Group Co Limited in the form of a SWOT analysis
- An in-depth view of the business model of Sinopharm Group Co Limited including a breakdown and examination of key business segments
- Intelligence on Sinopharm Group Co Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sinopharm Group Co Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sinopharm Group Co Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sinopharm Group Co Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sinopharm Group Co Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Sinopharm Group Co Limited: Company Overview
Sinopharm Group Co Limited: Overview and Key Facts
Sinopharm Group Co Limited: Overview
Sinopharm Group Co Limited: Key Facts
Sinopharm Group Co Limited: Key Employees
Sinopharm Group Co Limited: Key Employee Biographies
Sinopharm Group Co Limited: Major Products and Services
Sinopharm Group Co Limited: Company History
Sinopharm Group Co Limited: Management Statement
Sinopharm Group Co Limited: Locations and Subsidiaries
Sinopharm Group Co Limited: Key Competitors
Sinopharm Group Co Limited: Company Analysis
Sinopharm Group Co Limited: Business Description
Sinopharm Group Co Limited: SWOT Analysis
Sinopharm Group Co Limited: SWOT Overview
Sinopharm Group Co Limited: Strengths
Sinopharm Group Co Limited: Weaknesses
Sinopharm Group Co Limited: Opportunities
Sinopharm Group Co Limited: Threats
Sinopharm Group Co Limited: Corporate Financial Deals Activity
Sinopharm Group Co Limited: Financial Deals Overview
Sinopharm Group Co Limited: Targets and Partners
Sinopharm Group Co Limited: Top Deals 2016 – 2020YTD*
Sinopharm Group Co Limited: Advisors
Sinopharm Group Co Limited: Top Financial Advisors
Sinopharm Group Co Limited: Mergers and Acquisitions
Sinopharm Group Co Limited: Corporate Venturing
Sinopharm Group Co Limited: Capital Raising
Sinopharm Group Co Limited: Partnership
Sinopharm Group Co Limited: Recent Developments
Sinopharm Group Co Limited: News and Events Summary
Sinopharm Group Co Limited: Business Expansion
Sinopharm Group Co Limited: Contracts
Sinopharm Group Co Limited: Corporate Governance
Sinopharm Group Co Limited: Financial Deals
Sinopharm Group Co Limited: Financial Performance
Sinopharm Group Co Limited: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Sinopharm Group Co Limited: Key Facts
Table 2: Sinopharm Group Co Limited: Key Employees
Table 3: Sinopharm Group Co Limited: Company History
Table 4: Sinopharm Group Co Limited: Locations and Subsidiaries
Table 5: Sinopharm Group Co Limited: Key Competitors
Table 6: Sinopharm Group Co Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Sinopharm Group Co Limited: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Sinopharm Group Co Limited: M&A Average Deal Size - Value (US$m)
Table 9: Sinopharm Group Co Limited: Targets and Partners
Table 10: Sinopharm Group Co Limited: Top Deals 2016 - 2020YTD*
Table 11: Sinopharm Group Co Limited: Financial Advisor Ranking by Value (US$m)
Table 12: Sinopharm Group Co Limited: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Sinopharm Group Co Limited: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Sinopharm Group Co Limited: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 15: Sinopharm Group Co Limited: Corporate Venturing by Geography (2016 - YTD*2020)
Table 16: Sinopharm Group Co Limited: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 17: Sinopharm Group Co Limited: Capital Raising by Deal Type (2016 - YTD*2020)
Table 18: Sinopharm Group Co Limited: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 19: Sinopharm Group Co Limited: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 20: Sinopharm Group Co Limited: News and Events Summary
Table 21: Sinopharm Group Co Limited: Business Expansion
Table 22: Sinopharm Group Co Limited: Contracts
Table 23: Sinopharm Group Co Limited: Corporate Governance
Table 24: Sinopharm Group Co Limited: Financial Deals
Table 25: Sinopharm Group Co Limited: Financial Performance
Table 26: Sinopharm Group Co Limited: Strategy and Operations

★海外企業調査レポート[Sinopharm Group Co Limited：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Public Power Corporation SA：発電所・企業SWOT分析
    Public Power Corporation SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • Groupe Lactalis S.A.：企業の戦略・SWOT・財務情報
    Groupe Lactalis S.A. - Strategy, SWOT and Corporate Finance Report Summary Groupe Lactalis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Revance Therapeutics Inc (RVNC)：医療機器：M&Aディール及び事業提携情報
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Alecta Pensionsforsakring Omsesidigt：企業の戦略的SWOT分析
    Alecta Pensionsforsakring Omsesidigt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Thales Deutschland GmbH：企業の戦略・SWOT・財務情報
    Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Empire Co Ltd：企業の戦略・SWOT・財務情報
    Empire Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Empire Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Advanced Micro Devices Inc (AMD)：企業の財務・戦略的SWOT分析
    Advanced Micro Devices Inc (AMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Atmos Energy Corp (ATO)：企業の財務・戦略的SWOT分析
    Atmos Energy Corp (ATO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • F-star Biotechnology Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mA …
  • Enterprise Rent-A-Car Company：企業の戦略・SWOT・財務情報
    Enterprise Rent-A-Car Company - Strategy, SWOT and Corporate Finance Report Summary Enterprise Rent-A-Car Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Kerecis ehf：製品パイプライン分析
    Summary Kerecis ehf is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic and oral wounds, for dura m …
  • Brainsway Ltd (BRIN)：企業の財務・戦略的SWOT分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Aptevo Therapeutics Inc (APVO)：企業の財務・戦略的SWOT分析
    Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Autolus Therapeutics Plc (AUTL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Autolus Therapeutics Plc (Autolus), formerly Autolus Therapeutics Limited is a clinical-stage biopharmaceutical company which offers programmed T cell immunotherapies for the treatment of hematological cancers and solid tumors. The company utilizes its T-cell programming and manufacturing te …
  • Technip SA (TEC)-石油・ガス分野：企業M&A・提携分析
    Summary Technip SA (Technip) is a provider of project management, engineering and construction services to energy sector. It offers a comprehensive portfolio of technologies and services for the subsea oil and gas developments to the largest and most complex offshore and onshore infrastructures. The …
  • Open Text Corporation：企業のM&A・事業提携・投資動向
    Open Text Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Open Text Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Enbridge Energy Partners LP (EEP)：石油・ガス：M&Aディール及び事業提携情報
    Summary Enbridge Energy Partners LP (EEP) is a midstream energy partnership that owns and operates a diversified portfolio of crude oil and liquids transportation systems in the US. It provides services through interstate pipeline transportation and storage of crude oil and liquid petroleum. The par …
  • Boustead Heavy Industries Corporation Berhad：戦略・SWOT・企業財務分析
    Boustead Heavy Industries Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Boustead Heavy Industries Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • ENN Energy Holdings Ltd (2688)：企業の財務・戦略的SWOT分析
    ENN Energy Holdings Ltd (2688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ceska pojistovna a.s.：企業の戦略的SWOT分析
    Ceska pojistovna a.s. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆